vgx-3400
Vaccineexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2010 (NCT01142362)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vgx-3400
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01184976 | Phase 1 | Aug 1, 2010 | GeneOne Life Science, Inovio Pharmaceuticals, Korea University, Yonsei University |
| NCT01142362 | Phase 1 | Jun 1, 2010 | Accelovance, Inovio Pharmaceuticals, Vince & Associates |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Inovio Pharmaceuticals | For profit | 2 | 1 | 1 | 2010 |
| Accelovance | For profit | 1 | 0 | 1 | 2010 |
| GeneOne Life Science | For profit | 1 | 1 | 1 | 2010 |
| Korea University | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Vince & Associates | For profit | 1 | 0 | 1 | 2010 |
| Yonsei University | Academic/Hospital | 1 | 0 | 1 | 2010 |
6 organizations
Page 1 / 1